Sentiment-Signal
15,9
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Unternehmen & Branche
| Name | Inspire Medical Systems, Inc. |
|---|---|
| Ticker | INSP |
| CIK | 0001609550 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,59 Mrd. USD |
| Beta | 0,86 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 911,981,000 | 145,422,000 | 4.89 | 907,317,000 | 781,160,000 |
| 2025-09-30 | 10-Q | 224,501,000 | 9,932,000 | 0.34 | 807,716,000 | 666,460,000 |
| 2025-06-30 | 10-Q | 217,086,000 | -3,592,000 | -0.12 | 802,193,000 | 677,814,000 |
| 2025-03-31 | 10-Q | 201,317,000 | 2,992,000 | 0.10 | 730,809,000 | 635,743,000 |
| 2024-12-31 | 10-K | 802,804,000 | 53,509,000 | 1.75 | 808,383,000 | 689,695,000 |
| 2024-09-30 | 10-Q | 203,191,000 | 18,497,000 | 0.60 | 796,194,000 | 696,562,000 |
| 2024-06-30 | 10-Q | 195,885,000 | 9,793,000 | 0.32 | 728,389,000 | 638,071,000 |
| 2024-03-31 | 10-Q | 164,010,000 | -10,005,000 | -0.34 | 685,842,000 | 589,024,000 |
| 2023-12-31 | 10-K | 624,799,000 | -21,153,000 | -0.72 | 676,811,000 | 572,514,000 |
| 2023-09-30 | 10-Q | 153,302,000 | -8,540,000 | -0.29 | 639,494,000 | 544,180,000 |
| 2023-06-30 | 10-Q | 151,092,000 | -11,952,000 | -0.41 | 618,246,000 | 529,359,000 |
| 2023-03-31 | 10-Q | 127,897,000 | -15,424,000 | -0.53 | 571,847,000 | 504,648,000 |
| 2022-12-31 | 10-K | 407,856,000 | -44,881,000 | -1.60 | 564,876,000 | 496,008,000 |
| 2022-09-30 | 10-Q | 109,188,000 | -16,847,000 | -0.60 | 527,523,000 | 470,204,000 |
| 2022-06-30 | 10-Q | 91,386,000 | -14,490,000 | -0.53 | 292,002,000 | 226,984,000 |
| 2022-03-31 | 10-Q | 69,382,000 | -16,694,000 | -0.61 | 289,720,000 | 225,055,000 |
| 2021-12-31 | 10-K | 233,394,000 | -42,042,000 | -1.54 | 295,084,000 | 229,048,000 |
| 2021-09-30 | 10-Q | 61,685,000 | -10,347,000 | -0.38 | 278,894,000 | 220,300,000 |
| 2021-06-30 | 10-Q | 52,959,000 | -13,088,000 | -0.48 | 272,208,000 | 219,914,000 |
| 2021-03-31 | 10-Q | 40,352,000 | -16,216,000 | -0.60 | 273,413,000 | 223,131,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | mcCormick Shawn | Director | Open Market Sale | -1,200 | 139.00 | -166,800.00 | -66,4% | |
| 2025-11-28 | mcCormick Shawn | Director | Open Market Sale | -2,000 | 127.48 | -254,960.00 | -101,5% | |
| 2025-08-29 | Buchholz Richard | Officer, Chief Financial Officer | Open Market Sale | -11,000 | 93.39 | -1,027,290.00 | -408,9% | |
| 2025-08-08 | Curet Myriam | Director | Open Market Sale | -4 | 77.28 | -309.10 | -0,1% | |
| 2025-05-08 | Curet Myriam | Director | Open Market Sale | -2 | 153.22 | -306.45 | -0,1% | |
| 2025-05-02 | mcCormick Shawn | Director | Open Market Sale | -360 | 160.00 | -57,600.00 | -22,9% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.